Showing results (41-50 of 110) with videos related to
Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|September 1, 2017
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis BGeorge V Papatheodoridis, Spilios Manolakopoulos, Tung-Hung Su, et al.Annals of Gastroenterology|May 4, 2018
Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issuesNikolaos Papadopoulos, Maria Papavdi, Anna Pavlidou, et al.Journal of Gastroenterology and Hepatology|May 1, 2008
Long-term prognosis of cirrhotics with an upper gastrointestinal bleeding episode: does infection play a role?Jiannis Vlachogiannakos, Pantelis Sklavos, Nikos Viazis, et al.European Journal of Gastroenterology & Hepatology|November 6, 2019
Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort studySpilios Manolakopoulos, Athanasia Striki, Vasilios Papastergiou, et al.Annals of Gastroenterology|July 3, 2019
Aiming towards hepatitis C virus elimination in GreeceGeorge V Papatheodoridis, John Goulis, Vana Sypsa, et al.Annals of Gastroenterology|September 3, 2019
Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastographyNikolaos Papadopoulos, Sofia Vasileiadi, Maria Papavdi, et al.The American Journal of Gastroenterology|December 23, 2003
Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infectionSpilios Manolakopoulos, Stylianos Karatapanis, Jiannis Elefsiniotis, et al.BMC Gastroenterology|June 2, 2007
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective studySpilios Manolakopoulos, Sotirios Bethanis, Charis Liapi, et al.Journal of Hepatology|September 10, 2013
Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapyGeorge Papatheodoridis, John Goulis, Spilios Manolakopoulos, et al.BMC Gastroenterology|April 12, 2024
Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter studyHariklia Kranidioti, Konstantinos Zisimopoulos, Theodora Oikonomou, et al.Pageof 11